Quick Answer
PROCEPT BioRobotics Corp reported Diluted EPS of $1.72 per share (loss) for fiscal year 2025.
PROCEPT BioRobotics Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.72 | +1.7% |
| 2024 | -$1.75 | +21.9% |
| 2023 | -$2.24 | -14.3% |
| 2022 | -$1.96 | +46.0% |
| 2021 | -$3.63 | +74.9% |
| 2020 | -$14.47 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.38 | +5.0% | -8.6% |
| June 30, 2025 | -$0.35 | +30.0% | +22.2% |
| March 31, 2025 | -$0.45 | +11.8% | -12.5% |
| September 30, 2024 | -$0.40 | +21.6% | +20.0% |
| June 30, 2024 | -$0.50 | +10.7% | +2.0% |
| March 31, 2024 | -$0.51 | +19.0% | +0.0% |
| September 30, 2023 | -$0.51 | +0.0% | +8.9% |
| June 30, 2023 | -$0.56 | -30.2% | +11.1% |
- PROCEPT BioRobotics Corp showed an increase of +1.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2025 period, PROCEPT BioRobotics Corp’s diluted eps has grown by 88.1% (from $14.47 per share (loss) to $1.72 per share (loss)).
- The most recent figure is from PROCEPT BioRobotics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: